Aspirin Fails to Show Major Benefit in Preventing Colorectal Cancer Recurrence
21 Jan 2025
A new international clinical trial has found that three years of aspirin use after standard adjuvant therapy for high-risk Dukes’ B and C colorectal cancer did not significantly reduce disease recurrence. The trial, led by the National Cancer Center Singapore and published in The Lancet Gastroenterology & Hepatology, investigated the...
Read More
